HARCP

HEROIN ADDICTION AND
RELATED CLINICAL PROBLEMS

The official journal of
EUROPAD - European Opiate Addiction Treatment Association
WFTOD - World Federation for the Treatment of Opioid Dependence
Editor: Icro Maremmani, MD - Pisa, Italy, EU
Associate Editors:
Thomas Clausen, MD - Oslo, Norway
Pier Paolo Pani, MD - Cagliari, Italy, EU
Marta Torrens, MD - Barcelona, Spain, EU

HARCP Archives

Browse by volume Browse by article Published Ahead
of Print
 

 

 

If you want to download the journal, please login or register as reader.

2008 Issues

Cover

Vol. 10 • No. 1 • March 2008

In this issue:

  • Sexual Behaviour of Heroin Addicts In Treatment
    Brajević-Gizdić I., Pletikosa M.
  • First Experience of Opioid Therapy with Buprenorphine in Ukraine
    Dvoryak S., Grishayeva I.
  • Administration of Nalbuphine to Heroin Addicts. Feasibility and Short-Term Effects
    Voronkov M., Ocheret D., Bondarenko S., Yu Y. I., Koren S.
  • Evidence of Reliability and Validity of the Opiate Dosage Adequacy Scale (ODAS) in a Sample of Methadone Maintenance Patients
    González-Saiz F., Rojas O. L., Gómez R. B., Acedos I. B., Martínez J. G., Collantes M. A. G., Fernández A. L., Serum Methadone Levels Study Group
  • Improvement in the Quality of Live in Heroin Addicts: Differences Between Methadone and Buprenorphine Treatment
    Maremmani I., Pani P. P., Popovic D., Pacini M., Deltito J., Perugi G.
  • Methadone: A Fast and Powerful Anti-anxiety, Anti-depressant and Anti-psychotic Treatment
    Deglon J. J., Wark E.
  • Explaining Agonist Treatment Through Movie Language: The Interesting Allegory of ‘Videodrome'
    Pacini M.

 

Cover

Vol. 10 • No. 2 • June 2008

In this issue:

  • Evaluation of therapeutic alternatives to imprisonment for drug-dependent offenders. Findings of a comparative european multi-country study
    Uchtenhagen A., Stevens A., Berto D., Frick U., Hunt N., Kerschl V., Mcsweeney T., Puppo I., Santamaria A., Schaaf S., Steffan E., Gegenhuber B., Turnbull P., Werdenich W.
  • Motivational interventions for Methadone-Treated patients
    Kantchelov A.
  • Health care utilization and morbidity associated with Methadone and Buprenorphine Treatment
    Bell J., Butler B.
  • GPs' office based Metadone Maintenance Treatment in Trieste, Italy.Therapeutic efficacy and predictors of clinical response
    Michelazzi A., Vecchiet F., Leprini R., Popovic D., Deltito J., Maremmani I.
  • Use of Sertraline in depressed methadone maintenance patients
    Trajanovska A. S., Popovska O. S.

 

Cover

Vol. 10 • No. 3 • September 2008

In this issue:

  • When a New Drug Promotes the Integration of Treatment Modalities: Suboxone and Harm Reduction
    Maremmani I.
  • Pseudo-Addiction: The Illustrative Case of Howard Hughes
    Tennant F.
  • The Under-Treatment of Pain: A Global Problem. An Educational Approach
    Buttfield I.
  • Finnish Experience With Buprenorphine-Naloxone Combination (Suboxone®): Survey Evaluations With Intravenous Drug Users
    Simojoki K., Alho A.
  • Fifteen Years of Office-Based Prescribing in Croatia. Attitudes, Obstacles and Outcomes.
    Ivancic A.

 

Cover

Vol. 10 • No. 4 • December 2008

In this issue:

  • Buprenorphine-Naloxone Versus Methadone Maintenance Therapy: A Randomised Double-Blind Trial With Opioid-Dependent Patients
    Kamien J. B., Branstetter S. A., Amass L.
  • Predictors for Non-Relapsing Status in Methadone-Maintained Heroin Addicts. A Long-Term Perspective Study
    Maremmani I., Pacini M., Lamanna F., Pani P. P., Trogu M., Perugi G., Deltito J., Gerra G.
  • Unintentional and Intentional Injuries Due to Opiate Abuse
    Stenbacka M.
  • Scientific Evidence and Practical Experience with Methadone-Assisted Withdrawal of Heroin-Dependent Pregnant Patients
    Jones H.
  • Opioid Therapy and Restoration of the Immune Function in Heroin-Addicted Patients
    Somaini L., Giaroni C., Gerra G.
  • Major Policy and Clinical Developments in the Use of Methadone and Buprenorphine Treatment in the U.S.
    Parrino M. W.

 

 

AU-CNS Associazione per l’Utilizzo delle Conoscenze Neuroscientifiche a fini Sociali
Association for the Application of Neuroscientific Knowledge to Social Aims
Via XX Settembre, 83 – 55045 PIETRASANTA (Lucca) - Italy
P. IVA 01681650469 – Codice Fiscale 94002580465
Tel/Phone: 0584 - 790073 - Fax: 0584-72081 - Email: info@heroinaddictionrelatedclinicalproblems.org
Start of page